{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:27:52Z","timestamp":1759624072070,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ejogrb.2020.10.044","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T22:34:26Z","timestamp":1603233266000},"page":"154-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Soluble heat-shock protein 27 in blood serum is a non-invasive prognostic biomarker for ovarian cancer"],"prefix":"10.1016","volume":"255","author":[{"given":"Dominique","family":"K\u00f6nsgen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd","family":"Klinkmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karoline","family":"Diesing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jalid","family":"Sehouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioana","family":"Braicu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariane","family":"S\u00fcmnig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger H.H.","family":"Erb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias B.","family":"Stope","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Mustea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2020.10.044_bib0005","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.3802\/jgo.2016.27.e53","article-title":"Major clinical research advances in gynecologic cancer in 2015","volume":"27","author":"Suh","year":"2016","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cyto.2008.10.019","article-title":"Monitoring of IL-10 in the serum of patients with advanced ovarian cancer: results from a prospective pilot-study","volume":"45","author":"Mustea","year":"2009","journal-title":"Cytokine"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0015","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1210\/en.2011-2123","article-title":"Minireview: human ovarian cancer: biology, current management, and paths to personalizing therapy","volume":"153","author":"Romero","year":"2012","journal-title":"Endocrinol"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0020","first-page":"277","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-1-4757-3587-1_3","article-title":"Early detection of ovarian cancer: promise and reality","volume":"107","author":"Bast","year":"2002","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0030","doi-asserted-by":"crossref","first-page":"129s","DOI":"10.1200\/JCO.2003.04.003","article-title":"Progress in the management of gynecologic cancer: consensus summary statement","volume":"21","author":"Cannistra","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0035","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/ijgc-00009577-200511001-00015","article-title":"New tumor markers: CA125 and beyond","volume":"15","author":"Bast","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0040","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13048-016-0247-6","article-title":"High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma","volume":"9","author":"Morales-Vasquez","year":"2016","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0045","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ygyno.2007.10.017","article-title":"The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass","volume":"108","author":"Moore","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0050","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1515\/CCLM.2011.075","article-title":"The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?","volume":"49","author":"Montagnana","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0055","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ygyno.2012.07.106","article-title":"Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass","volume":"127","author":"Karlsen","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0060","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejca.2016.01.007","article-title":"Subjective assessment versus ultrasound models to diagnose ovarian cancer: a systematic review and meta-analysis","volume":"58","author":"Meys","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0065","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cca.2015.03.047","article-title":"HE4 in the differential diagnosis of ovarian masses","volume":"446","author":"Granato","year":"2015","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0070","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1038\/sj.onc.1209337","article-title":"MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer","volume":"25","author":"Xu","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0075","first-page":"113","article-title":"The small heat shock protein hsp27 increases invasiveness but decreases motility of breast cancer cells","volume":"17","author":"Lemieux","year":"1997","journal-title":"Invasion Metastasis"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0080","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nrurol.2013.108","article-title":"The role of heat shock proteins in bladder cancer","volume":"10","author":"Ischia","year":"2013","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0085","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/jnci\/85.19.1558","article-title":"Biological and clinical implications of heat shock protein 27,000 (Hsp27): a review","volume":"85","author":"Ciocca","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0090","doi-asserted-by":"crossref","first-page":"6595","DOI":"10.1158\/0008-5472.CAN-03-3998","article-title":"Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer","volume":"64","author":"Rocchi","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0095","first-page":"165","article-title":"HSP27 in patients with ovarian carcinoma: still an independent prognostic indicator at 60 months follow-up","volume":"25","author":"Geisler","year":"2004","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0100","first-page":"1343","article-title":"Prognostic value of HSP27 in head and neck squamous cell carcinoma: a retrospective analysis of 57 tumours","volume":"26","author":"Lo Muzio","year":"2006","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0105","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0002-9378(00)72431-8","article-title":"Serum antibodies to the 27-kd heat shock protein in women with gynecologic cancers","volume":"183","author":"Korneeva","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0110","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-2003-41864","article-title":"IMO\"--intraoperative mapping of ovarian cancer","volume":"125","author":"Sehouli","year":"2003","journal-title":"Zentralbl Gynakol"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0115","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.critrevonc.2015.08.008","article-title":"Jump in the fire - heat shock proteins and their impact on ovarian cancer therapy","volume":"97","author":"Stope","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0120","first-page":"3321","article-title":"Drug-induced modulation of heat shock protein HSPB1 in an ovarian cancer cell model","volume":"36","author":"Stope","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0125","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ygyno.2010.05.027","article-title":"Heat shock proteins in ovarian cancer: a potential target for therapy","volume":"119","author":"Cohen","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0130","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1006\/gyno.1998.4961","article-title":"Heat shock protein 27: an independent prognostic indicator of survival in patients with epithelial ovarian carcinoma","volume":"69","author":"Geisler","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0135","first-page":"1603","article-title":"Expression of the heat shock protein HSP27 in human ovarian cancer","volume":"1","author":"Langdon","year":"1995","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0140","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/PGP.0b013e31818b0f5e","article-title":"Expression and clinical role of antiapoptotic proteins of the bag, heat shock, and Bcl-2 families in effusions, primary tumors, and solid metastases in ovarian carcinoma","volume":"28","author":"Elstrand","year":"2009","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0145","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/(SICI)1097-0215(19990621)84:3<234::AID-IJC6>3.0.CO;2-9","article-title":"Heat-shock-protein-27 (hsp27) expression in ovarian carcinoma: relation in response to chemotherapy and prognosis","volume":"84","author":"Arts","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0150","first-page":"969","article-title":"Heat shock proteins and malignancies of the female genital tract","volume":"141","author":"Piura","year":"2002","journal-title":"Harefuah"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0155","first-page":"2967","article-title":"Co-expression of the MDR1 gene and HSP27 in human ovarian cancer","volume":"18","author":"Schneider","year":"1998","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0160","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1081\/IAS-120030525","article-title":"Detection of the soluble heat shock protein 27 (hsp27) in human serum by an ELISA","volume":"25","author":"De","year":"2004","journal-title":"J Immunoassay Immunochem"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0165","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/IGC.0b013e3181bf425b","article-title":"Concentrations of antibodies against heat shock protein 27 in the sera of women with ovarian carcinoma","volume":"19","author":"Olejek","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0170","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1575374","article-title":"Heat shock protein HSP27 secretion by ovarian cancer cells is linked to intracellular expression levels, occurs independently of the endoplasmic reticulum pathway and HSP27\u2019s phosphorylation status, and is mediated by exosome liberation","volume":"2017","author":"Stope","year":"2017","journal-title":"Dis Markers"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0175","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s13277-013-1139-7","article-title":"Heat shock protein 27: a potential biomarker of peritoneal metastasis in epithelial ovarian cancer?","volume":"35","author":"Zhao","year":"2014","journal-title":"Tumour Biol"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0180","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1177\/1933719111432875","article-title":"Increased expression of heat shock protein 27 correlates with peritoneal metastasis in epithelial ovarian cancer","volume":"19","author":"Zhao","year":"2012","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0185","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1038\/cddis.2011.104","article-title":"OGX-427 inhibits tumor progression and enhances gemcitabine chemotherapy in pancreatic cancer","volume":"2","author":"Baylot","year":"2011","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0190","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1158\/0008-5472.CAN-12-3979","article-title":"Hsp27 regulates epithelial mesenchymal transition, metastasis, and circulating tumor cells in prostate cancer","volume":"73","author":"Shiota","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0195","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.2174\/092986707782360079","article-title":"Anti-cancer therapeutic approaches based on intracellular and extracellular heat shock proteins","volume":"14","author":"Didelot","year":"2007","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0200","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/9780470754030.ch15","article-title":"HSP27: an anti-inflammatory and immunomodulatory stress protein acting to dampen immune function","volume":"291","author":"Miller-Graziano","year":"2008","journal-title":"Novartis Found Symp"},{"key":"10.1016\/j.ejogrb.2020.10.044_bib0205","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.4049\/jimmunol.165.7.3951","article-title":"Exaggerated human monocyte IL-10 concomitant to minimal TNF-alpha induction by heat-shock protein 27 (Hsp27) suggests Hsp27 is primarily an antiinflammatory stimulus","volume":"165","author":"De","year":"2000","journal-title":"J Immunol"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211520306825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211520306825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:50:09Z","timestamp":1759557009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211520306825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":41,"alternative-id":["S0301211520306825"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2020.10.044","relation":{},"ISSN":["0301-2115"],"issn-type":[{"type":"print","value":"0301-2115"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soluble heat-shock protein 27 in blood serum is a non-invasive prognostic biomarker for ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2020.10.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}